Favorable impact of virological response to highly active antiretroviral therapy on survival in patients with AIDS-related lymphoma (Q44234582)

1 December 2017

title

Favorable impact of virological response to highly active antiretroviral therapy on survival in patients with AIDS-related lymphoma (English)

1 reference

1 December 2017

0 references

José-Tomás Navarro

1 reference

1 December 2017

Josep-María Ribera

1 reference

1 December 2017

Albert Oriol

1 reference

1 December 2017

Joan Romeu

1 reference

1 December 2017

Guillem Sirera

1 reference

1 December 2017

José-Luis Mate

1 reference

1 December 2017

Montserrat Batlle

1 reference

1 December 2017

Blanca Xicoy

1 reference

1 December 2017

Javier Grau

1 reference

1 December 2017

Fuensanta Millá

1 reference

1 December 2017

Evarist Feliu

1 reference

1 December 2017

publication date

1 September 2002

1 reference

1 December 2017

1 reference

1 December 2017

1 reference

1 December 2017

1 reference

1 December 2017

page(s)

1837-1842

1 reference

Acquired immunodeficiency syndrome-related systemic non-Hodgkin's lymphoma

1 December 2017

cites work

1 reference

https://api.crossref.org/works/10.1080%2F1042819021000006402

Epidemiologic trends in HIV-associated lymphomas

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F1042819021000006402

Non-Hodgkin lymphoma in HIV-infected patients in the era of highly active antiretroviral therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F1042819021000006402

Influence of highly active anti-retroviral therapy on response to treatment and survival in patients with acquired immunodeficiency syndrome-related non-Hodgkin's lymphoma treated with cyclophosphamide, hydroxydoxorubicin, vincristine and prednisone

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F1042819021000006402

Impact of HAART on the clinical management of AIDS-related cancers

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F1042819021000006402

Better response to chemotherapy and prolonged survival in AIDS-related lymphomas responding to highly active antiretroviral therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F1042819021000006402

A predictive model for aggressive non-Hodgkin's lymphoma. The International Non-Hodgkin's Lymphoma Prognostic Factors Project

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F1042819021000006402

Report of an international workshop to standardize response criteria for non-Hodgkin's lymphomas. NCI Sponsored International Working Group

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F1042819021000006402

Nonparametric Estimation from Incomplete Observations

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F1042819021000006402

352. Note: Conservatism of the Approximation Σ(O - E) 2 /E in the Logrank Test for Survival Data or Tumor Incidence Data

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F1042819021000006402

Immune restoration with antiretroviral therapies: implications for clinical management

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F1042819021000006402

Age and serum lactate dehydrogenase level are independent prognostic factors in human immunodeficiency virus-related non-Hodgkin's lymphomas: a single-institute study of 96 patients.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F1042819021000006402

Epidemiological, biological and clinical features of HIV-related lymphomas in the era of highly active antiretroviral therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F1042819021000006402

10.1080/1042819021000006402

21 January 2018

Identifiers

DOI

1 reference

1 December 2017

1 reference